Active clinical trials for "Dry Eye Syndromes"

This is a multi-site, randomized, investigator-masked study to evaluate the physical effects of Systane(R) versus Refresh Tears(R) in subjects with moderate to severe dry eye. It is a 6-week, perspective, randomized, active-controlled, investigator-masked, parallel group study.

This study will evaluate the safety, efficacy, and acceptability of an eye drop formulation in subjects with dry eye disease.

The purpose of this pilot study is to evaluate the effect of diquafosol tetrasodium Ophthalmic Solution, 2% in dry eye subjects.

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

To determine if the types and amount of bacteria or other germs change over time after the routine procedure of blockage of tear drainage duct in the treatment of dry eye condition or other condition benefiting from a tear drainage blockage

To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.

A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.

To evaluate the effects of FID 114657 on the tear film lipid layer thickness of patients with dry eye.

This is a first-in-man study for the purpose of determining the safety and tolerability of LX214 ophthalmic solution in healthy volunteers and in patients with dry eye syndrome.

The purpose of this study is to verify whether OPC-12759 ophthalmic suspension is effective compared with active control in dry eye patients.